Mulroy Michael H. 4
4 · Lineage Cell Therapeutics, Inc. · Filed Mar 25, 2022
Insider Transaction Report
Form 4
Mulroy Michael H.
Director
Transactions
- Purchase
Common Shares, no par value
2022-03-24$1.40/sh+7,000$9,800→ 258,555 total
Footnotes (1)
- [F1]The price reported is a weighted average. The shares were purchased in multiple transactions at prices ranging from not less than $1.40 to not more than $1.41. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range.